Fondsen
Doorzoek alle in België verhandelde fondsen
Verfijnd zoeken naar fondsen die voldoen aan uw criteria
Fondsenzoeker
Turbo-list
Vergelijk Fondsen
Watch-list
Turbo-List
Beleggingsinstelling
Categorie Sector
AlgemeenRendementRating&RisicoKosten
26 - 50 of 360
FondsnaamKoers1 dag(%)1 week
(%)
1 maand
(%)
3 maand
(%)
1 jaar
(%)
YTD
(%)
Datum
Eleva Eleva Absolute R A EU 107,31 0,52  0,131,30 7,3926-7-2024
Alken Abs Rtn Eurp H k. 182,05 -0,54  3,071,339,297,3725-7-2024
Alken Abs Rtn Eurp EU1 k. 154,53 -0,53  3,061,299,127,2825-7-2024
AS SI II TR Credit Fd K£ u. 9,29 0,33  1,474,5213,067,2229-7-2024
AS SI II TR Credit Fd D£ u. 9,04 0,33  1,484,5012,987,1729-7-2024
AS SI II TR Credit Fd D£ k. 13,82 0,33  1,474,5113,037,1629-7-2024
AS SI II TR Credit Fd K£ k. 12,84 0,33  1,454,4813,047,1529-7-2024
AS SI II TR Credit Fd B£ k. 12,68 0,33  1,464,4912,957,1229-7-2024
Alken Abs Rtn Eurp I k. 167,76 -0,53  3,041,228,797,0925-7-2024
Alken Abs Rtn Eurp K€ k. 108,51 -0,54  3,031,218,787,0925-7-2024
BNYM IF BNY Mellon Ml T Shar k. 1,06 0,67  -0,272,097,986,9729-7-2024
BNYM IF BNY Mellon MltA NIS1 k. 2,96 0,67  -0,282,077,876,9729-7-2024
BNYM IF BNY Mellon Ml Inst W k. 1,91 0,67  -0,282,077,876,9629-7-2024
BNYM IF BNY Mellon MltAs D B k. 1,84 0,67  -0,292,047,736,8829-7-2024
Alken Abs Rtn Eurp A k. 146,28 -0,54  3,011,118,236,8125-7-2024
LyxIdx Smart Overnight R IG£ k. 1.350,76 0,02  1,173,357,356,7125-7-2024
LyxIdx Smart Overnight Re C£ k. 1.350,73 0,02  1,173,357,356,7125-7-2024
C-QUAD ARTS TR Bond VTA h k. 140,00 0,01  1,844,2312,476,5929-7-2024
BNYM IF BNY Mellon MltA Stlg k. 2,59 0,66  -0,331,897,096,5129-7-2024
LyxIdx Smart Overnight Re C£ k. 1.135,60 0,02  0,732,706,976,4929-7-2024
Eleva Eleva Absolute S A EU 1.073,53 0,46  0,181,41 6,4926-7-2024
LyxIdx Smart Overnight Re C£ k. 1.135,60 0,02  0,732,746,976,2729-7-2024
LyxIdx Smart Overnight R IG£ k. 1.135,42 0,05  0,732,716,966,2326-7-2024
LyxIdx Smart Overnight Re C£ k. 1.135,40 0,05  0,732,716,966,2326-7-2024
Moorea Sust Strc Inc MUHE 1.246,27 -0,33  -0,560,2611,416,1325-7-2024